NCT00897104View on ClinicalTrials.gov

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study (0462-029)

PHASE3CompletedINTERVENTIONAL
Enrollment

933

Participants

Timeline

Start Date

August 31, 1995

Primary Completion Date

May 31, 1996

Study Completion Date

September 30, 1996

Conditions
Migraine Headache
Interventions
DRUG

rizatriptan benzoate (MK0462)

single dose 5 mg rizatriptan p.o.

DRUG

Comparator: sumatriptan

single dose 50 mg sumatriptan p.o.

DRUG

Comparator: Placebo

Placebo to rizatriptan or sumatriptan, single dose placebo tablet taken orally

All Listed Sponsors
lead

Organon and Co

INDUSTRY